LRCX | ||
---|---|---|
OUTLOOK RATING 1..100 | 38 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 28 Undervalued | |
PROFIT vs RISK RATING 1..100 | 26 | |
SMR RATING 1..100 | 18 | |
PRICE GROWTH RATING 1..100 | 6 | |
P/E GROWTH RATING 1..100 | 39 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IXN | LRCX | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago55% |
Stochastic ODDS (%) | 4 days ago71% | 4 days ago70% |
Momentum ODDS (%) | 4 days ago83% | 4 days ago76% |
MACD ODDS (%) | 4 days ago90% | 4 days ago78% |
TrendWeek ODDS (%) | 4 days ago89% | 4 days ago78% |
TrendMonth ODDS (%) | 4 days ago87% | 4 days ago77% |
Advances ODDS (%) | 4 days ago88% | 4 days ago79% |
Declines ODDS (%) | 14 days ago80% | 14 days ago65% |
BollingerBands ODDS (%) | 4 days ago79% | 4 days ago70% |
Aroon ODDS (%) | 4 days ago90% | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SOXX | 255.64 | 0.45 | +0.18% |
iShares Semiconductor ETF | |||
FTQI | 20.50 | 0.03 | +0.15% |
First Trust Nasdaq BuyWrite Income ETF | |||
XHYF | 38.12 | N/A | N/A |
BondBloxx US Hg Yld Fncl & REIT Str ETF | |||
FSCS | 37.04 | -0.45 | -1.20% |
First Trust SMID Capital Strength ETF | |||
XPH | 46.50 | -1.11 | -2.33% |
SPDR® S&P Pharmaceuticals ETF |
A.I.dvisor indicates that over the last year, IXN has been closely correlated with STM. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if IXN jumps, then STM could also see price increases.